ZA981034B - Formulation of stabilized cationic transfection agent(s)/nucleic acid particles - Google Patents
Formulation of stabilized cationic transfection agent(s)/nucleic acid particlesInfo
- Publication number
- ZA981034B ZA981034B ZA981034A ZA981034A ZA981034B ZA 981034 B ZA981034 B ZA 981034B ZA 981034 A ZA981034 A ZA 981034A ZA 981034 A ZA981034 A ZA 981034A ZA 981034 B ZA981034 B ZA 981034B
- Authority
- ZA
- South Africa
- Prior art keywords
- nucleic acid
- transfection agent
- formulation
- acid particles
- cationic transfection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9701467A FR2759298B1 (fr) | 1997-02-10 | 1997-02-10 | Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA981034B true ZA981034B (en) | 1998-08-11 |
Family
ID=9503492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA981034A ZA981034B (en) | 1997-02-10 | 1998-02-09 | Formulation of stabilized cationic transfection agent(s)/nucleic acid particles |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1007097B1 (xx) |
JP (1) | JP2001511171A (xx) |
KR (1) | KR20000070914A (xx) |
AT (1) | ATE206932T1 (xx) |
AU (1) | AU737720B2 (xx) |
BR (1) | BR9807563A (xx) |
CA (1) | CA2278665A1 (xx) |
CZ (1) | CZ282199A3 (xx) |
DE (1) | DE69802102T2 (xx) |
DK (1) | DK1007097T3 (xx) |
ES (1) | ES2166146T3 (xx) |
FR (1) | FR2759298B1 (xx) |
GR (1) | GR3036919T3 (xx) |
HU (1) | HUP0001720A3 (xx) |
IL (1) | IL130765A0 (xx) |
NO (1) | NO993825D0 (xx) |
PT (1) | PT1007097E (xx) |
SK (1) | SK282685B6 (xx) |
WO (1) | WO1998034648A1 (xx) |
ZA (1) | ZA981034B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6359054B1 (en) * | 1994-11-18 | 2002-03-19 | Supratek Pharma Inc. | Polynucleotide compositions for intramuscular administration |
US6583301B1 (en) * | 1998-04-08 | 2003-06-24 | Celltech R & D Limited | Lipids |
CA2335393C (en) * | 1998-07-20 | 2008-09-23 | Inex Pharmaceuticals Corporation | Liposomal encapsulated nucleic acid-complexes |
AU2001241958A1 (en) * | 2000-03-03 | 2001-09-17 | Valentis, Inc. | Improved poloxamer and poloxamine compositions for nucleic acid delivery |
GB0009201D0 (en) * | 2000-04-14 | 2000-05-31 | Univ Nottingham | Cationic polymer - Nucleic acid complexes and methods of making them |
US20020091242A1 (en) | 2000-10-11 | 2002-07-11 | Michel Bessodes | Acid-sensitive compounds, their preparation and uses |
JP2004518693A (ja) * | 2000-10-20 | 2004-06-24 | バレンティス,インコーポレイティド | 虚血状態を処置するための遺伝子供給製剤および方法 |
EP1232758A1 (fr) * | 2001-02-19 | 2002-08-21 | Aventis Pasteur | Polynucléotide formulé en vue d'un transfert intracellulaire amélioré |
CA3031270A1 (en) * | 2004-03-03 | 2005-12-22 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
EP1861112A4 (en) | 2005-03-03 | 2009-07-22 | Revance Therapeutics Inc | COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
JP4653242B1 (ja) * | 2010-02-12 | 2011-03-16 | ナノキャリア株式会社 | 粒子状医薬組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1181937A3 (en) * | 1994-08-09 | 2004-02-04 | Cytrx Corporation | Novel vaccine adjuvant and vaccine |
AU5527696A (en) * | 1995-03-31 | 1996-10-16 | Children's Hospital Medical Center | Use of surfactants for introducing genetic material into lun g cells |
US6120794A (en) * | 1995-09-26 | 2000-09-19 | University Of Pittsburgh | Emulsion and micellar formulations for the delivery of biologically active substances to cells |
-
1997
- 1997-02-10 FR FR9701467A patent/FR2759298B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-06 BR BR9807563-2A patent/BR9807563A/pt not_active IP Right Cessation
- 1998-02-06 HU HU0001720A patent/HUP0001720A3/hu unknown
- 1998-02-06 PT PT98906986T patent/PT1007097E/pt unknown
- 1998-02-06 ES ES98906986T patent/ES2166146T3/es not_active Expired - Lifetime
- 1998-02-06 DE DE69802102T patent/DE69802102T2/de not_active Expired - Lifetime
- 1998-02-06 AT AT98906986T patent/ATE206932T1/de not_active IP Right Cessation
- 1998-02-06 JP JP53388198A patent/JP2001511171A/ja active Pending
- 1998-02-06 CZ CZ992821A patent/CZ282199A3/cs unknown
- 1998-02-06 IL IL13076598A patent/IL130765A0/xx unknown
- 1998-02-06 WO PCT/FR1998/000222 patent/WO1998034648A1/fr not_active Application Discontinuation
- 1998-02-06 DK DK98906986T patent/DK1007097T3/da active
- 1998-02-06 AU AU62987/98A patent/AU737720B2/en not_active Ceased
- 1998-02-06 SK SK1082-99A patent/SK282685B6/sk unknown
- 1998-02-06 CA CA002278665A patent/CA2278665A1/fr not_active Abandoned
- 1998-02-06 EP EP98906986A patent/EP1007097B1/fr not_active Expired - Lifetime
- 1998-02-06 KR KR1019997007179A patent/KR20000070914A/ko not_active Application Discontinuation
- 1998-02-09 ZA ZA981034A patent/ZA981034B/xx unknown
-
1999
- 1999-08-09 NO NO993825A patent/NO993825D0/no not_active Application Discontinuation
-
2001
- 2001-10-18 GR GR20010401473T patent/GR3036919T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1007097B1 (fr) | 2001-10-17 |
AU6298798A (en) | 1998-08-26 |
WO1998034648A1 (fr) | 1998-08-13 |
SK282685B6 (sk) | 2002-11-06 |
HUP0001720A1 (hu) | 2000-09-28 |
ATE206932T1 (de) | 2001-11-15 |
HUP0001720A3 (en) | 2001-10-29 |
NO993825L (no) | 1999-08-09 |
FR2759298B1 (fr) | 1999-04-09 |
CA2278665A1 (fr) | 1998-08-13 |
KR20000070914A (ko) | 2000-11-25 |
EP1007097A1 (fr) | 2000-06-14 |
PT1007097E (pt) | 2002-04-29 |
DE69802102T2 (de) | 2002-03-14 |
AU737720B2 (en) | 2001-08-30 |
SK108299A3 (en) | 2000-05-16 |
GR3036919T3 (en) | 2002-01-31 |
NO993825D0 (no) | 1999-08-09 |
BR9807563A (pt) | 2000-02-01 |
DK1007097T3 (da) | 2002-02-11 |
IL130765A0 (en) | 2001-01-28 |
CZ282199A3 (cs) | 1999-10-13 |
DE69802102D1 (de) | 2001-11-22 |
JP2001511171A (ja) | 2001-08-07 |
ES2166146T3 (es) | 2002-04-01 |
FR2759298A1 (fr) | 1998-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA981034B (en) | Formulation of stabilized cationic transfection agent(s)/nucleic acid particles | |
US6136294C1 (en) | Amino acid stabilized medical aerosol formulation | |
EP0911039A3 (en) | Drug-resin complexes stabilized by chelating agents | |
IL115742A0 (en) | Pharmaceutical compositions comprising a difficultly soluble active agent | |
HK1042444A1 (zh) | 藥用噴霧製劑 | |
IL172835A0 (en) | A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids | |
HK1028548A1 (en) | Formulations for hydrophobic pharmaceutical agents | |
WO2000032186A3 (en) | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents | |
CA2194979A1 (en) | Solid drug forms containing clathrates of steroid sex hormones | |
WO2000050046A8 (en) | Stabilized oral pharmaceutical composition containing iodide and iodate and method | |
YU8701A (sh) | Nova oralna kompozicija | |
AU1869601A (en) | Pharmaceutical compositions comprising trimegestone | |
RO117500B1 (ro) | Compoziţie cosmetică | |
BR9811985A (pt) | Dispositivo de dosagem | |
WO2002083891A3 (en) | Nucleic acids for inhibiting hairless protein expression and methods of use thereof | |
WO1998023260A3 (en) | Non-ionic surfactant vesicles as a delivery agent for nucleic acid | |
WO2001006963A3 (en) | Orthopaedic bone cement mixing container | |
WO1998023297A3 (en) | Particulate compositions | |
EP0891778A3 (en) | Agents for the prevention and/or treatment of radiation-induced disorders | |
Gorshkov et al. | Effects of Nitrogen-Containing Compounds on H sub 2 PtCl sub 6 Activity in Hydrosilication of Unsaturated Siloxane Rubbers | |
MX9706067A (es) | Composiciones liquidas que contienen tensoactivos alquil poliglicosidos para la limpieza industrial e institucional. | |
MX9708160A (es) | Composicion y aparato para la limpieza de superficies. | |
MX9603741A (es) | Composicion de liberacion mantenida. | |
SI1007097T1 (en) | Formulation of stabilised cationic transfection agent(s)/nucleic acid particles |